Targeted Early Detection Program in Men at High Genetic Risk for Prostate Cancer
NCT07645391 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2026-06-12
Summary
This study evaluates urinary biomarkers and PSA to help determine the best approach to early detection of prostate cancer in patients with an elevated familial risk.
Conditions
- Prostate Carcinoma
Interventions
- OTHER
-
Non-Interventional Study
Non-interventional study
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
University of Michigan Rogel Cancer Center
lead OTHER
Principal Investigators
-
Todd M Morgan, MD · University of Michigan Rogel Cancer Center
Eligibility
- Min Age
- 35 Years
- Max Age
- 70 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-01-01
- Primary Completion
- 2030-01-31
- Completion
- 2030-01-31
Countries
- United States
Study Locations
More Related Trials
-
Precision Medicine in the Prostate Cancer Care Pathway
NCT04763317 ·Status: RECRUITING
-
Identify Genes/Pathways Responsible for Progression From Low Risk to Higher Risk Prostate Cancer
NCT03789253 ·Status: RECRUITING
-
Prostate Cancer Prevention Clinic for Men With Risk of Familial Prostate Cancer
NCT05681416 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Performance of Inherited Risk Assessment for Predicting Prostate Cancer From Prostate Biopsy
NCT05295407 ·Status: RECRUITING
-
Urine Prostate Screening Integrated With MRI for Early Detection of Prostate Cancer, UPRISE Trial
NCT07526545 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Identification of Prostate Cancer Genes
NCT00342784 ·Status: COMPLETED
-
Patient and Provider Perspectives on Genetic Risk Profiling
NCT07741929 ·Status: RECRUITING
-
Precision-Based Genomics in Prostate Cancer
NCT04706663 ·Status: RECRUITING
-
Clinical Validity and Utility of Genomic-targeted Chemoprevention of PCa: Aim 4a
NCT02381015 ·Status: COMPLETED ·Phase: NA
-
Prostate Cancer Screening Among Men With High Risk Genetic Predisposition
NCT02053805 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of a Multimodal Strategy for Early Diagnosis of Men at High Genetic Risk of Prostate Cancer
NCT05333432 ·Status: WITHDRAWN ·Phase: NA
-
Assessing DNA Changes in High Risk Prostate Cancer to Determine Prognosis
NCT01350180 ·Status: WITHDRAWN
-
Early Detection of Prostate Cancer
NCT04556916 ·Status: RECRUITING ·Phase: NA
-
Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial
NCT04513717 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Study of Blood Samples From Older Patients at High Risk of Developing Prostate Cancer and From Healthy Male Participants
NCT00898274 ·Status: COMPLETED
-
A Tailored Polygenic Risk Score for Predicting Progression in Prostate Cancer Under Active Surveillance
NCT07491406 ·Status: COMPLETED
-
Prostate Cancer Screening in Men With Germline BRCA2 Mutations
NCT02154672 ·Status: COMPLETED
-
Streamlined Genetic Testing in Prostate Cancer
NCT04359758 ·Status: COMPLETED ·Phase: NA
-
Study in Predicting Outcome of Patients Undergoing Radiation Therapy for Prostate Cancer
NCT00045331 ·Status: COMPLETED ·Phase: NA
-
The IMPACT Study - Identification of Men With a Genetic Predisposition to ProstAte Cancer
NCT00261456 ·Status: ACTIVE_NOT_RECRUITING
-
Genetic Testing in Predicting Biomarkers of Recurrence in Patients With Prostate Cancer Undergoing Surgery
NCT00977457 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Early Prostate Cancer: Predicting Treatment Response
NCT03770351 ·Status: UNKNOWN
-
Prostate Risk Or Radiology Assessment Non-inferiority Design, Upfront MRI or Risk Calculator in Men With Suspected Prostate Cancer
NCT07422597 ·Status: RECRUITING ·Phase: NA
-
Immuno-molecular Approaches for Non-invasive Diagnosis of Prostate Cancer
NCT04702633 ·Status: COMPLETED
-
Optimizing Active Surveillance in Low-Risk Prostate Cancer: a Pilot Study
NCT05764005 ·Status: COMPLETED ·Phase: NA